# US 6,730,514 B2 · Stable human oral cancer cell carcinoma cell line

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 6,730,514 B2
- Document ID: US6730514B2
- Status: Granted
- Kind: B2
- Application number: 09/730,567
- Filed: 2000-12-07
- Published: 2002-08-15
- Granted: 2004-05-04
- Earliest claimed: 2000-12-07
- Inventors: Ranju Ralhan; Jatinder Kaur
- Web page: https://patentgrep.com/patent/US6730514B2

## CPC

- C12N 5/0693: {Tumour cells; Cancer cells}
- G01N 33/5011: {for testing antineoplastic activity}
- G01N 33/57557: {of other specific parts of the body, e.g. brain}
- G01N 2800/52: Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention is directed to a stable, continuous, human oral squamous cell carcinoma cell line from the floor of the mouth of a habitual tobacco consumer using a variety of growth supplements and complement mediated lysis to obtain a fibroblast free culture. This cell line has the ability to produce tumor in athymic nude mice. The cell line of the present invention constitutes a system that is suitable for detecting and screening for new and effective anti-cancer therapies. This cell line provides in vitro and in vivo (xenographts in athymic mice) oral tumor model which is useful for understanding molecular basis of oral cancer development, identifying targets for designing novel therapeutic strategies, testing new gene therapy approaches for oral cancer and testing novel synthetic retinoids for chemoprevention of oral cancer.

## Claims

### Claim 1

The human oral cancer cell line AMOS-III established and propagated in vitro from oral squamous cell carcinoma obtained from the mouth of a chronic tobacco chewer.
